Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




The Future for Targeted Therapy
Link ID 7477
Title The Future for Targeted Therapy
Url http://www.medscape.com/viewarticle/578164?src=rss
Description Review a novel approach to new targets in the RA inflammation cascade, presented at EULAR 2008.
Medscape Rheumatology
Category Articles > Rheumatology
Keywords
Date Aug 5, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Methotrexate Pharmacokinetics Point Toward Possible Alternative Dosing
  In patients with rheumatoid arthritis (RA), it can take 6 months for oral methotrexate (MTX) to reach steady-state blood levels, according to a study by researchers in New Zealand published in the November issue of Arthritis & Rheumatism. The authors also found that in patients who had discontinued MTX, elimination of the drug from red blood cells was also slow. Reuters Health Information
Category:   Articles > Rheumatology


2. New Lupus Drug Wins Green Light in Europe
  The first new treatment for lupus in a half century was recommended for approval in Europe on Friday, offering a new option for patients and underpinning multibillion-dollar sales expectations for its makers. Reuters Health Information
Category:   Articles > Rheumatology


3. Recent Advances in the Therapeutic Management of Fibromyalgia: An Expert Interview With Rollin M. Ga
  Dr. Gallagher (UPenn Center for Pain Education, Philadelphia VA Medical Center) discusses advances in the therapeutic management of fibromyalgia, as illustrated by data from ACR 2007.
Medscape Rheumatology
Category:   Articles > Rheumatology


4. Evaluation of Multiplex Antinuclear Antibody Assay in Pediatric Patients
  Might multiplex antinuclear antibody assay be reliable enough to replace immunofluorescence assay as a screening method for evaluation of rheumatologic disorders in children less than 16 years of age?
Laboratory Medicine
Category:   Articles > Rheumatology


5. CCR5 Antagonist AZD5672 Ineffective in Rheumatoid Arthritis
  Despite showing promise in preclinical studies, the CCR5 antagonist AZD5672 was no better than placebo in patients with rheumatoid arthritis, researchers report in the online July 26th Arthritis & Rheumatism. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS